Study Stopped
Study requires Medicines Control council approval
ROTEM and Dietary Supplements
Viscoelastic Point-of-Care Coagulation Monitoring and Dietary Supplements: A Randomized, Double-blind, Placebo-controlled Trial
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Dietary Supplements can affect platelet activation and aggregation, which could result in bleeding tendencies. This study wishes to evaluate the influence that these supplements has on platelet function using Rotational thromboelastometry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2017
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2017
CompletedFirst Posted
Study publicly available on registry
April 24, 2017
CompletedStudy Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedMay 9, 2018
May 1, 2018
1 month
March 27, 2017
May 3, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Platelet dysfunction determined by ROTEM when consuming ginger, garlic, ginkgo biloba and ginseng.
To determine if viscoelastic point-of-care coagulation monitoring (ROTEM) detects abnormalities in platelet function when subjects consume ginger, garlic, ginkgo biloba and ginseng within their recommended daily allowances. ExTEM and FibTEM analysis will be performed and difference in MCF values will determine if there is platelet dysfunction or not.
2-4 weeks
Study Arms (5)
Ginger
ACTIVE COMPARATORGinger ( Zingiber officinale) 4 grams po dly for 14 days
Garlic
ACTIVE COMPARATORGarlic (Allium sativum) 4-12 mg alliin po dly for 14 days
Ginkgo Biloba
ACTIVE COMPARATORGinkgo Biloba 40mg po tds for 14 days
Ginseng
ACTIVE COMPARATORGinseng 400mg po dly for 14 days
Placebo
PLACEBO COMPARATORPlacebo po dly for 14 days
Interventions
Eligibility Criteria
You may qualify if:
- Age 18-60 years
- Both males and females
- Healthy volunteers
- Smokers and Non-smokers
- Staff frequenting the theatre complex at Steve Biko Academic Hospital
You may not qualify if:
- History of any chronic medical or psychiatric illness.
- Current excessive alcohol intake - more than 14 units a week in woman and more than 21 units a week in men.
- Pregnant or lactating mothers.
- Possible planned surgery during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jayde V Wyngaard, MBCHB
University of Pretoria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Each participant will be blinded to the dietary supplement which they will be taking. The medical technologist doing the ROTEM will be blinded to the dietary supplements as well.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
March 27, 2017
First Posted
April 24, 2017
Study Start
June 1, 2017
Primary Completion
July 1, 2017
Study Completion
August 1, 2017
Last Updated
May 9, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share